Phase II study of two-weekly temozolomide in patients with high-grade gliomas

Journal of Clinical Neuroscience

Volumn 13, Issue 1, 2006, Pages 18-22

  Wong, Shirley ^a,e   Rosenthal, Mark A ^a   Dowling, Anthony ^b   Jennens, Ross ^a   Woods, Anne Marie ^a   Ashley, David ^c   Cher, Lawrence ^d  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d AUSTIN HEALTH   (Australia)

^e WESTERN HOSPITAL   (Australia)

Author keywords

Glioma; Temozolomide

Indexed keywords

SEROTONIN ANTAGONIST; TEMOZOLOMIDE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GLIOMA; HUMAN; LETHARGY; LUNG EMBOLISM; MALE; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEPSIS; SUBDURAL HEMATOMA; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 30344445372     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2004.10.018     Document Type: Article

References (20)

1. P.C. Burger, F.S. Vogel, and S.B. Green Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications Cancer 56 1985 1011 1106
2. E. Burton, and M. Prados New chemotherapy options for the treatment of malignant gliomas Curr Opin Oncol 11 1999 157 161
3. W.K. Yung, M.D. Prados, and R. Yaya-Tur Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse: Temodal Brain Tumor Group J Clin Oncol 17 1999 2762 2771
4. M. Brada, K. Hoang-Xuan, and R. Rampling Multicentre phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse Ann Oncol 12 2001 259 266
5. M.T. Harris, M.A. Rosenthal, D. Ashley, and L. Cher An Australian experience with temozolomide for the treatment of recurrent high-grade gliomas J Clin Neurosci 8 2001 325 327
6. S.M. Lee, N. Thatcher, D. Crowther, and G.P. Margison Inactivation of O6-methyleguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide Br J Cancer 69 1994 452 456
7. S.R. Wedge, J.K. Porteus, B.L. May, and E.S. Newlands Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro Br J Cancer 73 1996 482 490
8. H.S. Friedman, T. Kerby, and H. Calvert Temozolomide and treatment of malignant glioma Clin Cancer Res 6 2000 2585 2597
9. E. Newlands, G. Blackledge, and J. Slack Phase I trial of temozolomide Br J Cancer 65 1992 287 291
10. C.S. Brock, E.S. Newlands, and S.R. Wedge Phase I trial of temozolomide using an extended continuous oral schedule Cancer Res 58 1998 4363 4367
11. R. Simon Optimal two-stage designs for the phase II clinical trials Control Clin Trials 10 1989 1 10
12. th Annual European Conference on Cancer (ECCO) 2001.
13. O.L. Chinot, S. Honore, and H. Dufour Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy J Clin Oncol 19 2001 2449 2455
14. M.J. Van Den Bent, O. Chinot, and W. Boogerd Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV chemotherapy: EORTC Brain Tumour Group phase II study 26972 Ann Oncol 14 2003 599 602
15. K. Vera, L. Djafari, and S. Faivre Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumours Ann Oncol 15 2004 161 171
16. M.A. Rosenthal, M.L. Gruber, and J. Glass Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme J Neuro-Oncol 47 2000 59 63
17. S. Chua, M.A. Rosenthal, and S. Wong Phase II study of temozolomide and caelyx in patients with recurrent glioblastoma multiforme Neuro-oncol 6 2004 38 43
18. M.A. Rosenthal, D.L. Ashley, and L. Cher Temozolamide-induced flare in high-grade gliomas: a new clinical entity Intern Med J 32 2002 346 348
19. D.R. Macdonald, T.L. Cascino, S.C. Schold Jr, and J.G. Cairncross Response criteria for Phase II studies of supratentorial malignant gliomas J Clin Oncol 8 1990 1277 1280
20. M.R. Gilbert Neuro-oncology clinical trials: promise and pitfalls Ann Oncol 12 2001 149 155